Suchergebnisse - "Karita, Etienne"

PubPharm (286)

1

HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection : A Multicenter Sub-Saharan African Study

enthalten in: Open forum infectious diseases | 2024

von Lindquist, L. | Kilembe, W. | Karita, E. | +11

2

High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope

enthalten in: PLoS pathogens | 2023

von Mopuri, R. | Welbourn, S. | Charles, T. | +12

3

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults : A Phase 1/2a Study

enthalten in: The Journal of infectious diseases | 2023

von Stieh, D. | Barouch, D. | Comeaux, C. | +45

4

Associations between punitive policies and legal barriers to consensual same-sex sexual acts and HIV among gay men and other men who have sex with men in sub-Saharan Africa : a multicountry, respondent-driven sampling survey

enthalten in: The lancet. HIV | 2023

von Lyons, C. | Twahirwa Rwema, J. | Makofane, K. | +20

CommentIn: Lancet HIV. 2023 Mar;10(3):e148-e149. - PMID 36623536

5

Developing a diversity, equity and inclusion compass to guide scientific capacity strengthening efforts in Africa

enthalten in: PLOS global public health | 2023

von Kasprowicz, V. | Waddilove, K. | Chopera, D. | +8

6

Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign

enthalten in: The Journal of infectious diseases | 2023

von Nyombayire, J. | Ingabire, R. | Magod, B. | +14

7

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women : study protocol for a phase 3 open-label randomized controlled trial

enthalten in: Trials | 2022

von Karita, E. | Nyombayire, J. | Ingabire, R. | +15

8

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial

enthalten in: Trials | 2022

von Karita, E. | Nyombayire, J. | Ingabire, R. | +15

9

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial

enthalten in: Trials | 2022

von Karita, E. | Nyombayire, J. | Ingabire, R. | +15

10

Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors

enthalten in: Frontiers in virology (Lausanne, Switzerland) | 2022

von Umviligihozo, G. | Mann, J. | Jin, S. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]